Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Oncology

Journal Scan / Research · March 21, 2013

Three Major Genes Associated With Poor Survival in Pancreatic Cancer

Annals of Surgery

 

Additional Info

Annals of Surgery
Immunohistochemically Detected Expression of 3 Major Genes (CDKN2A/p16, TP53, and SMAD4/DPC4) Strongly Predicts Survival in Patients With Resectable Pancreatic Cancer
Ann. Surg 2013 Mar 06;[EPub Ahead of Print], M Oshima, K Okano, S Muraki, et al

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading